REPORT ID 20415

China Open-Angle Glaucoma - Pipeline Market Research Report 2016

Publish Date
14-Oct
Pages
117
Format
Electronic (PDF)

Notes:
Sales, means the sales volume of Open-Angle Glaucoma - Pipeline
Revenue, means the sales value of Open-Angle Glaucoma - Pipeline

This report studies Open-Angle Glaucoma - Pipeline in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
    Birken AG
    Fibrocell Science,Inc.
    GlaxoSmithKline Plc
    InMed Pharmaceuticals Inc.
    Karus Therapeutics Limited
    RegeneRex Biopharmaceuticals,Inc.
    Scioderm,Inc.
    Shire Plc
    Stratatech Corporation

Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
    Type I
    Type II
    Type III
Split by Application, this report focuses on consumption, market share and growth rate of  Open-Angle Glaucoma - Pipeline in each application, can be divided into
    Application 1
    Application 2
    Application 3

 
			   
Table of Contents

China Open-Angle Glaucoma - Pipeline Market Research Report 2016
1 Open-Angle Glaucoma - Pipeline Market Overview
    1.1 Product Overview and Scope of Open-Angle Glaucoma - Pipeline
    1.2 Open-Angle Glaucoma - Pipeline Segment by Type
        1.2.1 China Production Market Share of Open-Angle Glaucoma - Pipeline Type in 2015
        1.2.2 Type I
        1.2.3 Type II
        1.2.4 Type III
    1.3 Applications of Open-Angle Glaucoma - Pipeline
        1.3.1 Open-Angle Glaucoma - Pipeline Consumption Market Share by Application in 2015
        1.3.2 Application 1
        1.3.3 Application 2
        1.3.4 Application 3
    1.4 China Market Size (Value) of Open-Angle Glaucoma - Pipeline (2011-2021)
    1.5 China Open-Angle Glaucoma - PipelineStatus and Outlook
    1.6 Government Policies

2 China Open-Angle Glaucoma - Pipeline Market Competition by Manufacturers
    2.1 China Open-Angle Glaucoma - Pipeline Capacity, Production and Share by Manufacturers (2015 and 2016)
    2.2 China Open-Angle Glaucoma - Pipeline Revenue and Share by Manufacturers (2015 and 2016)
    2.3 China Open-Angle Glaucoma - Pipeline Average Price by Manufacturers (2015 and 2016)
    2.4 Manufacturers Open-Angle Glaucoma - Pipeline Manufacturing Base Distribution, Sales Area, Product Type
    2.5 Open-Angle Glaucoma - Pipeline Market Competitive Situation and Trends
        2.5.1 Open-Angle Glaucoma - Pipeline Market Concentration Rate
        2.5.2 Open-Angle Glaucoma - Pipeline Market Share of Top 3 and Top 5 Manufacturers

3 China Open-Angle Glaucoma - Pipeline Manufacturers Profiles/Analysis
    3.1 Birken AG
        3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.1.2 Open-Angle Glaucoma - Pipeline Product Type, Application and Specification
            3.1.2.1 Type I
            3.1.2.2 Type II
        3.1.3 Birken AG Open-Angle Glaucoma - Pipeline Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.1.4 Main Business/Business Overview
    3.2 Fibrocell Science,Inc.
        3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.2.2 117 Product Type, Application and Specification
            3.2.2.1 Type I
            3.2.2.2 Type II
        3.2.3 Fibrocell Science,Inc. 117 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.2.4 Main Business/Business Overview
    3.3 GlaxoSmithKline Plc
        3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.3.2 130 Product Type, Application and Specification
            3.3.2.1 Type I
            3.3.2.2 Type II
        3.3.3 GlaxoSmithKline Plc 130 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.3.4 Main Business/Business Overview
    3.4 InMed Pharmaceuticals Inc.
        3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.4.2 Oct Product Type, Application and Specification
            3.4.2.1 Type I
            3.4.2.2 Type II
        3.4.3 InMed Pharmaceuticals Inc. Oct Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.4.4 Main Business/Business Overview
    3.5 Karus Therapeutics Limited
        3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.5.2  Product Type, Application and Specification
            3.5.2.1 Type I
            3.5.2.2 Type II
        3.5.3 Karus Therapeutics Limited  Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.5.4 Main Business/Business Overview
    3.6 RegeneRex Biopharmaceuticals,Inc.
        3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.6.2 Million USD Product Type, Application and Specification
            3.6.2.1 Type I
            3.6.2.2 Type II
        3.6.3 RegeneRex Biopharmaceuticals,Inc. Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.6.4 Main Business/Business Overview
    3.7 Scioderm,Inc.
        3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.7.2 Pharma & Healthcare Product Type, Application and Specification
            3.7.2.1 Type I
            3.7.2.2 Type II
        3.7.3 Scioderm,Inc. Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.7.4 Main Business/Business Overview
    3.8 Shire Plc
        3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.8.2  Product Type, Application and Specification
            3.8.2.1 Type I
            3.8.2.2 Type II
        3.8.3 Shire Plc  Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.8.4 Main Business/Business Overview
    3.9 Stratatech Corporation
        3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.9.2  Product Type, Application and Specification
            3.9.2.1 Type I
            3.9.2.2 Type II
        3.9.3 Stratatech Corporation  Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.9.4 Main Business/Business Overview

4 China Open-Angle Glaucoma - Pipeline Capacity, Production, Revenue, Consumption, Export and Import (2011-2016)
    4.1 China Open-Angle Glaucoma - Pipeline Capacity, Production and Growth (2011-2016)
    4.2 China Open-Angle Glaucoma - Pipeline Revenue and Growth (2011-2016)
    4.3 China Open-Angle Glaucoma - Pipeline Production, Consumption, Export and Import (2011-2016)

5 China Open-Angle Glaucoma - Pipeline Production, Revenue (Value), Price Trend by Type
    5.1 China Open-Angle Glaucoma - Pipeline Production and Market Share by Type (2011-2016)
    5.2 China Open-Angle Glaucoma - Pipeline Revenue and Market Share by Type (2011-2016)
    5.3 China Open-Angle Glaucoma - Pipeline Price by Type (2011-2016)
    5.4 China Open-Angle Glaucoma - Pipeline Production Growth by Type (2011-2016)

6 China Open-Angle Glaucoma - Pipeline Market Analysis by Application
    6.1 China Open-Angle Glaucoma - Pipeline Consumption and Market Share by Application (2011-2016)
    6.2 China Open-Angle Glaucoma - Pipeline Consumption Growth Rate by Application (2011-2016)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Application
        6.3.2 Emerging Markets/Countries

7 Open-Angle Glaucoma - Pipeline Manufacturing Cost Analysis
    7.1 Open-Angle Glaucoma - Pipeline Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Open-Angle Glaucoma - Pipeline

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Open-Angle Glaucoma - Pipeline Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Open-Angle Glaucoma - Pipeline Major Manufacturers in 2015
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 China Open-Angle Glaucoma - Pipeline Market Forecast (2016-2021)
    11.1 China Open-Angle Glaucoma - Pipeline Capacity, Production, Revenue Forecast (2016-2021)
    11.2 China Open-Angle Glaucoma - Pipeline Production, Import, Export and Consumption Forecast (2016-2021)
    11.3 China Open-Angle Glaucoma - Pipeline Production Forecast by Type (2016-2021)
    11.4 China Open-Angle Glaucoma - Pipeline Consumption Forecast by Application (2016-2021)
    11.5 Open-Angle Glaucoma - Pipeline Price Forecast (2016-2021)

12 Research Findings and Conclusion

13 Appendix
    Author List
    Disclosure Section
    Research Methodology
    Data Source
    China Disclaimer